Axis / Avigilon Patent Litigation Ends With 3 Invalidated Patents
The multi-year, multi-district patent litigation between Canon and Axis against Avigilon is ended, with 3 Avigilon video analytics patents being invalidated in the process.
In this report, we examine:
- Legal Battle (2017-2020)
- Axis and Avigilon Comments
- Axis' Litigation Spending
- 3 Invalidated Patents
- Other Cases – Dismissed, Settled, Appealed
- Patent License Program
- Business Impact
Executive *******
**** *****'* *******, **** ************ ********* Avigilon's ****** ********* ******* *** *** the ******** ** ************ *******. ******** lost *** ******* ** **** * ObjectVideo ******* *********** ** ***** *********. The ********* **** *** **** ** an ********* ****** *** **********.
Legal ****** (****-****)
***** ***** **** ******** ** ****, ******** ************ ** **** ** their ******* ('***, '***, '***, '***, '630). *** **** **** *** ******* in *** **** *** *****, *** another ***** ** *************. ***** **** rare ****** ************ ***** *** *****, which****** ********* ** ******* **** ******* ********* ***** *'*************' ******** **** ***** '*********** *********' to ****** **********.
**** ********** *** ******* ** ********'* patent ********* *******, ** ******** **** IPVM ** **** **** "***** *** ***** ********** ********* ***** benefit **** ************* ** *** *******". ******** ***** ~$*** ******* ********* patent ******** *********$** ******* *** ****** *****'*** **** **$**+ ******* *** * ******* ** other ******** *******. ******** ********* ** ***** **** for ********* ** *** ******* ** one ** *** *** ********* ******* the *** *********.
*** ***** ****** ****** **** **** moving ** ********** * ******** ******* over *** **** *** *****, **** July **** ** **** ****. ** these, * **** ***********, * ** the *********** ******* ** ***** ***** appealed, *** *** ***** ****** ****** was ****** ** **** ****.
Axis *** ******** ********
**** **** **** *** ****** *********, Canon *** ********, **** ****** ** dismiss *** *****, ******:
***** *** ******** **** ** ** agreement ********* **** **** *** ***** are *********. **** **** ** **** respect *** ******* *** ** ** important, *** ***, ** ***** ** leverage **** *********** *** ***********.
******** ******** ** ******* ** *** litigation *** *** ******* ** *** Avigilon ****** ********* ******* **** **** stopped *********, ***** ** ******* ***** in *** ****.
Axis' ********** ********
****, *** ***** *****, ***** ** IPVM ********* $*+ ******* *** ** the ***** ** *** ***** ***** between *** *** *******, ****. ***** cases ******** ******** ******* *** **** place ** ******** *************, **** * years. ** **** ** ********** ******** by ********** *** *** ******** *** appealing ***** **** **** ****** **********.
Invalidated ******* ('***, '***, '***)
********'* ******** *******, * ***** ******** **** ********* method, *** *********** ** **** *, **** ***** ******* **************:
*** ******** ********** ***** ******** *** ********** ************ in ********* *, **** ************** ***** ****** ********'* ******* *** rehearing:
**** ********** ******* ****'******* ******* ****** '***, ** ***** ************* **** *** ***** ******** *** annulled ** ********* *, **** ********:
Other ***** – *********, *******, ********
** **** **** ** *** *********, other ******* ***** **** *** **** settled, ******* ****** **********.
- *** ******* ***** ******** *** ****** infringement ** *** ****, *****, *** Massachusetts **** *** ******* *********, *** latest ******* ** **** ****
- ****'****** ************ ************** ********'*** ************* ***********, *** *** ****** *** ********* and ******* *********.
- ****'***** ****** ****** (***) *************** ********'*** ************* *** ****** ** ****/**/** ******** ******* *** ********* ** decision.
Patent ******* *******
******** ** ** ****** ************ ****** ********* ******* ** *** website, **** ******** ************* *** ***** in ** ****** *********** ******** *********:
***** ***** ******** ** ******** *********, Avigilon's ****** ********* ******* ** ********** to ******* *** ***-******** ********** *** will ** ********** *** ********** ** a ****-**-**** ***** ****** *******.
******** ********** ******** *** ********* ******* as * ***** ****** ******* ******. In ****, ********'* ** ** ********* Chris **************** *** *******:
*** ******* ******* ***** *********** ******* available ** ******** ************, ********* **** with ******* ******* ** *******. ** encourage *** ********** ********* ** **** the ******* ******* ** ****** ********* of *** ***** ******* ****.
Business ******
***** **** ** * **** *** Avigilon, ** ****** **** ** ** immaterial ** ********. ********'* ******* / previous *** ******* *** ****** ********* strategy **** ********'* ***** *** ********* (bought ** *** *** ** **** after *** ***** ******* **%). *** that ******** **** ********, ******** *** shown ** ** ******* ** ******* products *** ****** ********* *** ******** never ****** *** ****** ********* **** when **** ******** ******** **** ****.
**** ** * *** *** ****, though ** * ***-******* *******. ** the ***** ****, ***** ***** ******* dollar **** ****, ** ** * reasonable ********** *** *** ********* ****** licensing **** **** ***** **** ********* been ****** ** ***.
**** *******, **** ** * *** for ***** ********* **** ******* **** Axis' *******.
Poll / ****
**** *** *** ***** ***** ****** royalties ** ******** ***** ******* *** program? **** ********* ***** ****** ** have ***** ********.
* ***'* **** * **** ** licensees ***** *** *** * ******** quite * *** ** ******* ********* were ** **. **** **** * **** ***** ******* where *********** ** *** ** *********. ***, ironically, *****, ********, *** ** ******* are *** ***** ** ********.
*** ******* *** ********* ** **** many ** *** ******* ** *** portfolio *** ***** *****. *** **** those *** '*****' *** **** ******* could ** *******, * ***'* ****.
***, **** ** ****,** / ******** ********* *******:
** *** **** *.** ***** (**** - ** ****), ****** ***** ****** licensing ******** ********* ~$** ******* ***** revenue ****:
$*.* ******* **** *******
$*.* ******* **** *******
$*.* ******* **-** **** *******
**** **** *** ***** **** ** no **** ***** ** *** ********. Plus **** ** **** ********* *** obviously ***** ***** **** *** **** of ***** ******* *** ******* ***** old ** **** ***** (*.*., **** ~2000).
* ***'* **** * **** ** licensees ***** *** *** * ******** quite * *** ** ******* ********* were ** **.
**** ** ** ** ******** ****.
** *** **** ****** ********* ** this ***** *** ****** ***** ** hear **** ******** **** ******* *** anything.
* ****** ***** ** ******* **** the ******** **** ***** ***** ***:
*** ****** ***** ****** ** *******, “Looks **** ** **** **** ***** house ***** ****** ********* ******!”